Taken together, the findings suggest that MYC suppression, particularly in conjunction with C170 induces tumor cell immunity by disrupting multiple DNA damage repair pathways among other potential mechanisms in human neuroblastoma tumor cells. This evidence concerns the gene MYC and neoplasm.